Megatal, Crispr/Cas9, and Talen T-Cell Receptor Gene Editing
Mark J. Osborn(University of Minnesota), Bruce R. Blazar(University of Minnesota Medical Center), Anthony P. DeFeo(University of Minnesota), Jeffrey S. Miller(Science Museum of Minnesota), Jordan Jarjour(Biogen (United States)), Daniel F. Voytas(University of Minnesota), Colby G. Starker(University of Minnesota), Manfred Schmidt(Centre National de la Recherche Scientifique), Jakub Tolar(University of Minnesota System), Andrew M. Scharenberg(CTI BioPharma (Italy)), Sarah C. Merkel(University of Minnesota), Keli L. Hippen(University of Minnesota Medical Center), Amber McElroy(University of Minnesota Medical Center), Alexander Astrakhan(Seattle University), Christof von Kalle(Luxembourg Institute of Health), Friederike Knipping(German Cancer Research Center), Beau R. Webber(University of Minnesota), Richard Gabriel(German Cancer Research Center), Cara-lin Lonetree(University of Minnesota)
Cited by 0
Related Papers
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k